Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study ; volume:22 ; number:1 ; day:13 ; month:12 ; year:2023 ; pages:1-12 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (13.12.2023), 1-12, 12.2023

Creator: Simon, Tracey G.
Ebrahimi, Fahim
Roelstraete, Bjorn
Hagström, Hannes
Sundström, Johan
Ludvigsson, Jonas F.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12933-023-02070-5

URN: urn:nbn:de:101:1-2024022810445917869866

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Simon, Tracey G.
Ebrahimi, Fahim
Roelstraete, Bjorn
Hagström, Hannes
Sundström, Johan
Ludvigsson, Jonas F.
SpringerLink (Online service)

Other Objects (12)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma

Atrial tachy-arrhythmias associated with massive edema in the newborn

Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review

Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Related objects

Reset password